Abiopharma

New Form 10-Q - Alto Ingredients, Inc. Filed: 2025-05-09 AccNo: 0001213900-25-041532 Size: 4 MB

New Form PRE 14A - VERU INC. Filed: 2025-05-09 AccNo: 0001140361-25-018161 Size: 1 MB

New Form 8-K - IN8BIO, INC. Filed: 2025-05-09 AccNo: 0001193125-25-116901 Size: 159 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 4 - Fulcrum Therapeutics, Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068038 Size: 5 KB

Westlake - Westlake Corporation Declares Quarterly Dividend

New Form SCHEDULE 13G - ADMA BIOLOGICS, INC. Filed: 2025-05-09 AccNo: 0000914208-25-000192 Size: 13 KB

Westlake Corporation Declares Quarterly Dividend

New Form 144 - Zai Lab Ltd Filed: 2025-05-09 AccNo: 0001959173-25-003016 Size: 8 KB

New Form 8-K - InfuSystem Holdings, Inc Filed: 2025-05-09 AccNo: 0001628280-25-024273 Size: 3 MB Item 7.01: Regulation FD Disclosure

New Form SD - ELI LILLY & Co Filed: 2025-05-09 AccNo: 0000059478-25-000142 Size: 29 KB

New Form S-8 - APTARGROUP, INC. Filed: 2025-05-09 AccNo: 0001104659-25-046730 Size: 199 KB

New Form 8-K - DEXCOM INC Filed: 2025-05-09 AccNo: 0001093557-25-000129 Size: 762 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form 8-K - Athira Pharma, Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068020 Size: 399 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form DEFA14A - Lyra Therapeutics, Inc. Filed: 2025-05-09 AccNo: 0001193125-25-116890 Size: 11 KB

New Form SCHEDULE 13G/A - TENET HEALTHCARE CORP Filed: 2025-05-09 AccNo: 0000914208-25-000190 Size: 7 KB